Skip to main content
2025 CRT Conference Main banner

CRT 2025

Technology and Innovation

Innovation HUB Best Innovation Competition

Novel Aortocaval Shunt Technology | Improving Long-Term Outcomes in EVAR by Addressing Residual Aneurysm Sac

Monday, March 10, 2025
4:24 PM – 4:32 PM ET

    Speaker(s)

  • Matthew Kuhn, MS

    CEO
    Taurus Vascular
    Houston, Texas, United States

    Disclosure(s): Taurus Vascular: Employee (Ongoing)

Disclosure(s):
Matthew Kuhn, MS: Taurus Vascular: Employee (Ongoing)